Natural variability in the disease course of SSc-ILD: implications for treatment

Interstitial lung disease (ILD) affects approximately 50% of patients with systemic sclerosis (SSc) and is the leading cause of death in SSc. Our objective was to gain insight into the progression of SSc-associated ILD (SSc-ILD). Using data from longitudinal clinical trials and observational studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Vonk, Madelon C., Walker, Ulrich A., Volkmann, Elizabeth R., Kreuter, Michael, Johnson, Sindhu R., Allanore, Yannick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489046/
https://www.ncbi.nlm.nih.gov/pubmed/33762426
http://dx.doi.org/10.1183/16000617.0340-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489046/
https://www.ncbi.nlm.nih.gov/pubmed/33762426
http://dx.doi.org/10.1183/16000617.0340-2020

Ejemplares similares